R 84760

Drug Profile

R 84760

Latest Information Update: 28 Mar 2000

Price : $50

At a glance

  • Originator Sankyo
  • Class Opioid analgesics
  • Mechanism of Action Opioid kappa receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Pain

Most Recent Events

  • 28 Mar 2000 No-Development-Reported for Pain in Japan (Unknown route)
  • 29 Apr 1997 A study has been added to the pharmacodynamics section
  • 05 Oct 1995 Two studies have been added to the pharmacodynamics section ,.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top